KYMR has announced that partner Sanofi SNY will not advance the development of lead IRAK4 degrader KT-474. This setback was somewhat offset by KYMR’s announcement of an exclusive option and license ...

Kymera Therapeutics, Inc. has announced an update to its partnership with Sanofi regarding the advancement of a ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

Vuzix Corporation (NASDAQ:VUZI) is one of the 12 best-augmented reality stocks to buy, according to analysts. On June 24, ...

Danish allergy immunotherapy specialist ALK Abello today announced the first market launch of EURneffy (epinephrine) 2mg (the ...